Physician profile
Antonio Uria
NPI 1821173709
$1,348.15
in general payments reported to CMS, 2019-2025
22 companies · $356 in 2025
The $356 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $134 · 2021: $89.35 · 2022: $190 · 2023: $186 · 2024: $210 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $751.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $260.94 | 2024-2025 | Novosorb Btm |
| Allergan, INC. | $156.06 | 2019-2022 | |
| Abbvie INC. | $114.76 | 2019-2025 | Botox |
| Galderma Laboratories, L.P. | $107.13 | 2019-2024 | Dysport |
| Sun Pharmaceutical Industries INC. | $98.08 | 2022-2024 | Absorica Ld, Winlevi |
| Apyx Medical Corporation | $73.53 | 2019-2020 | |
| Sientra, INC. | $64.86 | 2022 | |
| Merz North America, INC. | $58.48 | 2019-2023 | Xeomin |
| Amgen INC. | $54.48 | 2022-2023 | Otezla |
| Tela Bio, INC. | $45.56 | 2024 | Ovitex 2s |
| Journey Medical Corporation | $43.88 | 2022-2023 | |
| Integra Lifesciences Corporation | $42.58 | 2020-2021 | |
| Stryker Corporation | $42.39 | 2025 | Spy-Phi System |
| Incyte Corporation | $40.50 | 2021-2022 | |
| Genzyme Corporation | $26.66 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $23.49 | 2023 | Acumed, Inframe Implant, Osteomed |
| Janssen Biotech, INC. | $19.79 | 2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $19.49 | 2025 | Sotyktu |
| Mimedx Group, INC. | $16.57 | 2025 | |
| Smith+Nephew, INC. | $14.36 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $12.36 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $12.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Uria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.